COSMOS study launched

April 26, 2008

Email this news item to a friend/colleague

The Hospital San Carlos, Madrid, Spain has started to recruit patients into a randomized study of closed peripheral intravenous systems versus open systems. The research team have named it the COSMOS Study (great name… lets hope the results are out of this world).

The purpose of this study is to investigate, in a prospective and randomized fashion, the clinical performance of a closed intravenous system (Nexiva®) versus an open conventional one (Vasocan®), with respect to ease of handling and effectiveness (as defined by time of survival without complications), security provided to professionals and patients against accidental blood exposure or needlestick injury, catheter-related complications such as phlebitis, pain and blockage and overall costs of the two systems.

Primary Outcome Measures:

Length of time catheter remains in place without clinical symptoms.

Secondary Outcome Measures:

Incidence of complications of the catheter, bacterial colonization of catheter tips and costs of therapy.

The study is due to complete July 2008. Click here for further information.